PANZYGA is in a class of medicine called intravenous immunoglobulin (IVIg). PANZYGA is a liquid medicine for infusion that contains immunoglobulin G (IgG).
*Eligible, commercially insured patients may pay as little as $0 for PANZYGA and may receive a maximum benefit of $12,500 per year or the cost of patient’s co-pay in a 12-month period (whichever is less) for claims received by the program. Terms and conditions/eligibility requirements apply. See full terms and conditions at PanzygaCoPay.com
- Patients must have commercial insurance to be eligible
- Patients are not eligible if they are enrolled in a state or federally funded insurance program